Literature DB >> 18708447

Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice.

Wen Su1, Zhenheng Guo, David C Randall, Lisa Cassis, David R Brown, Ming C Gong.   

Abstract

Human Type 2 diabetes is associated with increased incidence of hypertension and disrupted blood pressure (BP) circadian rhythm. Db/db mice have been used extensively as a model of Type 2 diabetes, but their BP is not well characterized. In this study, we used radiotelemetry to define BP and the circadian rhythm in db/db mice. We found that the systolic, diastolic, and mean arterial pressures were each significantly increased by 11, 8, and 9 mmHg in db/db mice compared with controls. In contrast, no difference was observed in pulse pressure or heart rate. Interestingly, both the length of time db/db mice were active (locomotor) and the intensity of locomotor activity were significantly decreased in db/db mice. In contrast to controls, the 12-h light period average BP in db/db mice did not dip significantly from the 12-h dark period. A partial Fourier analysis of the continuous 72-h BP data revealed that the power and the amplitude of the 24-h period length rhythm were significantly decreased in db/db mice compared with the controls. The acrophase was centered at 0141 in control mice, but became scattered from 1805 to 0236 in db/db mice. In addition to BP, the circadian rhythms of heart rate and locomotor activity were also disrupted in db/db mice. The mean arterial pressure during the light period correlates with plasma glucose, insulin, and body weight. Moreover, the oscillations of the clock genes DBP and Bmal1 but not Per1 were significantly dampened in db/db mouse aorta compared with controls. In summary, our data show that db/db mice are hypertensive with a disrupted BP, heart rate, and locomotor circadian rhythm. Such changes are associated with dampened oscillations of clock genes DBP and Bmal1 in vasculature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708447      PMCID: PMC2593501          DOI: 10.1152/ajpheart.00257.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  46 in total

1.  Contractile responses in spontaneously diabetic mice. II. Effect of cholestyramine on enhanced contractile response of aorta to norepinephrine in C57BL/KsJ (db/db) mice.

Authors:  N Kanie; K Kamata
Journal:  Gen Pharmacol       Date:  2000-12

Review 2.  Coordination of circadian timing in mammals.

Authors:  Steven M Reppert; David R Weaver
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

3.  The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains.

Authors:  K P Hummel; D L Coleman; P W Lane
Journal:  Biochem Genet       Date:  1972-08       Impact factor: 1.890

4.  Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (c57bl/6j db/db and c57bl/ksj db/db).

Authors:  K Gärtner
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

5.  Altered circadian rhythm of blood pressure and cerebrovascular damage.

Authors: 
Journal:  Blood Press Monit       Date:  1997-12       Impact factor: 1.444

6.  Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins.

Authors:  Zsolt Bagi; Nora Erdei; Attila Toth; Wei Li; Thomas H Hintze; Akos Koller; Gabor Kaley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-09       Impact factor: 8.311

7.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Authors:  D Koya; M Haneda; H Nakagawa; K Isshiki; H Sato; S Maeda; T Sugimoto; H Yasuda; A Kashiwagi; D K Ways; G L King; R Kikkawa
Journal:  FASEB J       Date:  2000-03       Impact factor: 5.191

Review 8.  Sleep disorders and the failure to lower nocturnal blood pressure.

Authors:  Michael G Ziegler
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-01       Impact factor: 2.894

9.  Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes.

Authors:  Peng Y Woon; Pamela J Kaisaki; José Bragança; Marie-Thérèse Bihoreau; Jonathan C Levy; Martin Farrall; Dominique Gauguier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-29       Impact factor: 11.205

10.  Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy.

Authors:  V Spallone; L Bernardi; L Ricordi; P Soldà; M R Maiello; A Calciati; S Gambardella; P Fratino; G Menzinger
Journal:  Diabetes       Date:  1993-12       Impact factor: 9.461

View more
  55 in total

1.  Altered clock gene expression and vascular smooth muscle diurnal contractile variations in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhongwen Xie; Zhenheng Guo; Marilyn J Duncan; Jenny Lutshumba; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

Review 2.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

3.  Novel mechanism of blood pressure regulation by forkhead box class O1-mediated transcriptional control of hepatic angiotensinogen.

Authors:  Yajuan Qi; Kebin Zhang; Yuxin Wu; Zihui Xu; Qian Chen Yong; Rajesh Kumar; Kenneth M Baker; Qinglei Zhu; Shouwen Chen; Shaodong Guo
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

Review 4.  The utility of animal models to evaluate novel anti-obesity agents.

Authors:  Steven P Vickers; Helen C Jackson; Sharon C Cheetham
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.

Authors:  K Huynh; H Kiriazis; X-J Du; J E Love; K A Jandeleit-Dahm; J M Forbes; J R McMullen; R H Ritchie
Journal:  Diabetologia       Date:  2012-02-29       Impact factor: 10.122

6.  Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation.

Authors:  Zhongwen Xie; Wen Su; Shu Liu; Guogang Zhao; Karyn Esser; Elizabeth A Schroder; Mellani Lefta; Harald M Stauss; Zhenheng Guo; Ming Cui Gong
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

Review 7.  Adipokines and blood pressure control.

Authors:  Frederique Yiannikouris; Manisha Gupte; Kelly Putnam; Lisa Cassis
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

8.  Cardiovascular and autonomic phenotype of db/db diabetic mice.

Authors:  Danielle Senador; Keerthy Kanakamedala; Maria Claudia Irigoyen; Mariana Morris; Khalid M Elased
Journal:  Exp Physiol       Date:  2009-02-13       Impact factor: 2.969

9.  Circadian control of mouse heart rate and blood pressure by the suprachiasmatic nuclei: behavioral effects are more significant than direct outputs.

Authors:  W John Sheward; Erik Naylor; Seymour Knowles-Barley; J Douglas Armstrong; Gillian A Brooker; Jonathan R Seckl; Fred W Turek; Megan C Holmes; Phyllis C Zee; Anthony J Harmar
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

10.  Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock.

Authors:  Julia V Busik; Maria Tikhonenko; Ashay Bhatwadekar; Madalina Opreanu; Nafissa Yakubova; Sergio Caballero; Danny Player; Takahiko Nakagawa; Aqeela Afzal; Jennifer Kielczewski; Andrew Sochacki; Stephanie Hasty; Sergio Li Calzi; Sungjin Kim; Shane K Duclas; Mark S Segal; Dennis L Guberski; Walter J Esselman; Michael E Boulton; Maria B Grant
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.